Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 51

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Can Global Initiative for Chronic Obstructive Lung Disease Stage 0 Provide Prognostic Information on Long-term Mortality in Men?

Stavem, Knut, Sandvik, Leiv, Erikssen, Jan·2006·Chest
DOI 10.1378/chest.130.2.318
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1378/chest.130.2.318

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 47

  1. Higgins, 1970, Predictors of mortality in the adult population of Tecumseh, Arch Environ Health, 21, 418, 10.1080/00039896.1970.10667260 · DOI
  2. Krzyzanowski, 1986, The relation of thirteen-year mortality to ventilatory impairment and other respiratory symptoms: the Cracow Study, Int J Epidemiol, 15, 56, 10.1093/ije/15.1.56 · DOI
  3. Bang, 1993, The effect of pulmonary impairment on all-cause mortality in a national cohort, Chest, 103, 536, 10.1378/chest.103.2.536 · DOI
  4. Cook, 1988, Breathlessness, lung function and the risk of heart attack, Eur Heart J, 9, 1215, 10.1093/oxfordjournals.eurheartj.a062432 · DOI
  5. Kannel, 1983, Vital capacity as a predictor of cardiovascular disease: the Framingham study, Am Heart J, 105, 311, 10.1016/0002-8703(83)90532-X · DOI
  6. Ebi-Kryston, 1988, Respiratory symptoms and pulmonary function as predictors of 10-year mortality from respiratory disease, cardiovascular disease, and all causes in the Whitehall study, J Clin Epidemiol, 41, 251, 10.1016/0895-4356(88)90129-1 · DOI
  7. Lange, 1991, Ventilatory function impairment and risk of cardiovascular death and of fatal or non-fatal myocardial infarction, Eur Respir J, 4, 1080, 10.1183/09031936.93.04091080 · DOI
  8. Tockman, 1989, Respiratory risk factors and mortality: longitudinal studies in Washington County, Maryland, Am Rev Respir Dis, 140, S56, 10.1164/ajrccm/140.3_Pt_2.S56 · DOI
  9. Strachan, 1991, Ventilatory function as a predictor of fatal stroke, BMJ, 302, 84, 10.1136/bmj.302.6768.84 · DOI
  10. Rodriguez, 1994, Pulmonary function decline and 17-year total mortality: the Honolulu Heart Program, Am J Epidemiol, 140, 398, 10.1093/oxfordjournals.aje.a117262 · DOI
  11. Cullen, 1983, Multiple regression analysis of risk factors for cardiovascular disease and cancer mortality in Busselton, Western Australia: 13-year study, J Chronic Dis, 36, 371, 10.1016/0021-9681(83)90169-8 · DOI
  12. Hole, 1996, Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study, BMJ, 313, 711, 10.1136/bmj.313.7059.711 · DOI
  13. James, 1999, Associations between white blood cell count, lung function, respiratory illness and mortality: the Busselton Health Study, Eur Respir J, 13, 1115, 10.1034/j.1399-3003.1999.13e29.x · DOI
  14. Ebi-Kryston, 1989, Breathlessness, chronic bronchitis and reduced pulmonary function as predictors of cardiovascular disease mortality among men in England, Scotland and the United States, Int J Epidemiol, 18, 84, 10.1093/ije/18.1.84 · DOI
  15. Wiles, 1991, Relevance of airflow obstruction and mucus hypersecretion to mortality, Respir Med, 85, 27, 10.1016/S0954-6111(06)80207-6 · DOI
  16. Vestbo, 1988, Should we continue using questionnaires on breathlessness in epidemiologic surveys?, Am Rev Respir Dis, 137, 1114, 10.1164/ajrccm/137.5.1114 · DOI
  17. Menotti, 1991, All cause mortality and its determinants in middle aged men in Finland, the Netherlands, and Italy in a 25 year follow up, J Epidemiol Commun Health, 45, 125, 10.1136/jech.45.2.125 · DOI
  18. Olofson, 1987, Mortality related to smoking habits, respiratory symptoms and lung function, Eur J Respir Dis, 71, 69
  19. 1960, Medical Research Council's Committee on the Aetiology of Chronic Bronchitis. Standardized questionnaires on respiratory symptoms, BMJ (Clin Res), 2, 1665
  20. Annesi, 1986, Is respiratory mucus hypersecretion really an innocent disorder? A 22-year mortality survey of 1,061 working men, Am Rev Respir Dis, 134, 688
  21. Vestbo, 2002, Can GOLD Stage 0 provide information of prognostic value in chronic obstructive pulmonary disease?, Am J Respir Crit Care Med, 166, 329, 10.1164/rccm.2112048 · DOI · Paper page
  22. Mannino, 2003, Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study, Thorax, 58, 388, 10.1136/thorax.58.5.388 · DOI · Paper page
  23. Stavem, 2005, Lung function, smoking and mortality in a 26-year follow-up of healthy middle-aged males, Eur Respir J, 25, 618, 10.1183/09031936.05.00008504 · DOI
  24. Erikssen, 1978, Smoking, lung function, physical performance and latent coronary heart disease in presumably healthy middle-aged men, Acta Med Scand, 203, 509, 10.1111/j.0954-6820.1978.tb14917.x · DOI
  25. Rose, 1968, Cardiovascular survey methods.
  26. Quanjer, 1983, Summary of recommendations, Bull Eur Physiopathol Respir, 19, 7
  27. Gulsvik, 2001, Expiratory and inspiratory forced vital capacity and one-second forced volume in asymptomatic never-smokers in Norway, Clin Physiol, 21, 648, 10.1046/j.1365-2281.2001.00377.x · DOI
  28. Samet, 1978, A historical and epidemiologic perspective on respiratory symptoms questionnaires, Am J Epidemiol, 108, 435, 10.1093/oxfordjournals.aje.a112642 · DOI
  29. Cox, 1972, Regression models and life tables, J R Stat Soc (B), 34, 187, 10.1111/j.2517-6161.1972.tb00899.x · DOI · Paper page
  30. Grambsch, 1994, Proportional hazards tests and diagnostics based on weighted residuals, Biometrics, 81, 515, 10.1093/biomet/81.3.515 · DOI · Paper page
  31. Sorlie, 1989, Mortality associated with respiratory function and symptoms in advanced age: The Framingham Study, Am Rev Respir Dis, 140, 379, 10.1164/ajrccm/140.2.379 · DOI
  32. Ekberg-Aronsson, 2005, Mortality in GOLD stages of COPD and its dependence on symptoms of chronic bronchitis, Respir Res, 6, 98, 10.1186/1465-9921-6-98 · DOI
  33. Vestbo, 1991, Are respiratory symptoms and chronic airflow limitation really associated with an increased risk of respiratory cancer?, Int J Epidemiol, 20, 375, 10.1093/ije/20.2.375 · DOI
  34. Lange, 1990, Ventilatory function and chronic mucus hypersecretion as predictors of death from lung cancer, Am Rev Respir Dis, 141, 613, 10.1164/ajrccm/141.3.613 · DOI
  35. Rosengren, 1998, Respiratory symptoms and long-term risk of death from cardiovascular disease, cancer and other causes in Swedish men, Int J Epidemiol, 27, 962, 10.1093/ije/27.6.962 · DOI
  36. Lange, 1990, Relation of ventilatory impairment and of chronic mucus hypersecretion to mortality from obstructive lung disease and from all causes, Thorax, 45, 579, 10.1136/thx.45.8.579 · DOI
  37. Zeiner-Henriksen, 1976, Six year mortality related to cardiorespiratory symptoms and environmental risk factors in a sample of the Norwegian population, J Chronic Dis, 29, 15, 10.1016/0021-9681(76)90065-5 · DOI
  38. Peto, 1983, The relevance in adults of air-flow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease: results from 20 years of prospective observation, Am Rev Respir Dis, 128, 491, 10.1164/arrd.1983.128.3.491 · DOI
  39. Vestbo, 2002, Epidemiological studies in mucus hypersecretion, Novartis Found Symp, 248, 3, 10.1002/0470860790.ch2 · DOI
  40. Lochen, 1992, The Tromso study: physical fitness, self reported physical activity, and their relationship to other coronary risk factors, J Epidemiol Commun Health, 46, 103, 10.1136/jech.46.2.103 · DOI
  41. Blair, 1989, Physical fitness and all-cause mortality: a prospective study of healthy men and women, JAMA, 262, 2395, 10.1001/jama.1989.03430170057028 · DOI · Paper page
  42. Blane, 1996, Association of cardiovascular disease risk factors with socioeconomic position during childhood and during adulthood, BMJ, 313, 1434, 10.1136/bmj.313.7070.1434 · DOI
  43. Smith, 1998, Individual social class, area-based deprivation, cardiovascular disease risk factors, and mortality: the Renfrew and Paisley Study, J Epidemiol Community Health, 52, 399, 10.1136/jech.52.6.399 · DOI
  44. Shohaimi, 2004, Area deprivation predicts lung function independently of education and social class, Eur Respir J, 24, 157, 10.1183/09031936.04.00088303 · DOI
  45. Leffondre, 2002, Modeling smoking history: a comparison of different approaches, Am J Epidemiol, 156, 813, 10.1093/aje/kwf122 · DOI
  46. 1995, Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society, Am J Respir Crit Care Med, 152, S77
  47. Antonelli-Incalzi, 2003, Do GOLD stages of COPD severity really correspond to differences in health status?, Eur Respir J, 22, 444, 10.1183/09031936.03.00101203 · DOI

Cited by

See all 51

Metadata

Authors
Stavem, K., Sandvik, L., & Erikssen, J.
Venue
Chest
Publisher
Elsevier BV
Published
2006-08
Volume
130
Issue
2
Pages
318-325
ISSN
0012-3692
DOI
10.1378/chest.130.2.318
Cited by
51
References
4
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Can Global Initiative for Chronic Obstructive Lung Disease Stage 0 Provide Prognostic Information on Long-term Mortality in Men? https://app.cochat.ai/papers/10.1378/chest.130.2.318
The paper
Stavem, K., Sandvik, L., & Erikssen, J. (2006). Can Global Initiative for Chronic Obstructive Lung Disease Stage 0 Provide Prognostic Information on Long-term Mortality in Men? Chest. https://doi.org/10.1378/chest.130.2.318

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.